Find out all about your favorite commercial!

Advertisers

Advertisers of the AstraZeneca TV Spot, 'Asthma or COPD'

AstraZeneca TV commercial - Asthma or COPD
AstraZeneca

AstraZeneca is a research-based biopharmaceutical company that is dedicated to pushing the boundaries of science and delivering life-changing medicines. The company's purpose underpins everything it d...

What the AstraZeneca TV commercial - Asthma or COPD is about.

AstraZeneca TV commercial - Asthma or COPD

Title: AstraZeneca TV Spot: 'Asthma or COPD'

Opening Scene:

The commercial begins with a soothing melody playing in the background as the scene fades in to reveal a beautiful, serene park on a sunny day. People of all ages are seen strolling, enjoying picnics, and engaging in outdoor activities.

Narrator (Voiceover):

:

"Are you experiencing shortness of breath, wheezing, or a persistent cough? It could be a sign of a respiratory condition called Asthma or Chronic Obstructive Pulmonary Disease, also known as COPD."

Visuals:

The camera then transitions to showcase a diverse group of individuals, each representing a different age group and background, all exhibiting symptoms of respiratory conditions. The scenes unfold in various settings such as a bustling city street, a suburban neighborhood, and a rural farm.

Narrator (Voiceover):

"Whether you're young or old, living in a city or the countryside, respiratory conditions can affect anyone, anywhere."

Visuals:

The scene shifts to a doctor's office, where a caring physician enters the frame, addressing a patient who is ready to seek help. The doctor offers reassurance and a diagnosis, providing a sense of empowerment and clarity for the patient.

Narrator (Voiceover):

"But there's hope. With AstraZeneca's innovative treatments and ongoing research, we are committed to helping you breathe easier and live life to the fullest."

Visuals:

Cutting to a sleek laboratory, scientists clad in white lab coats are shown collaborating, conducting research, and developing cutting-edge medical advancements.

Narrator (Voiceover):

"Our dedicated team of experts are passionate about finding new and effective ways to manage and treat asthma and COPD. We believe in a future where no one has to compromise their quality of life due to respiratory conditions."

Visuals:

The commercial concludes with an uplifting montage of people engaging in various activities, radiating joy and vitality. Happiness and freedom wash over their faces as they live their lives without being restricted by their conditions.

Narrator (Voiceover):

"Take the first step towards a better tomorrow. Consult with your healthcare provider and discover how AstraZeneca can help you regain control of your respiratory condition. Breathe freely. Live fully."

Closing Scene:

The screen fades to black, and the AstraZeneca logo appears, accompanied by soft instrumental music, leaving viewers inspired and hopeful.

Disclaimer:

The commercial ends with a brief disclaimer, reminding viewers to consult with their healthcare provider about their specific medical condition and not to discontinue any prescribed medications without professional guidance.

Note: This fictional TV spot for AstraZeneca is not based on any specific advertisement and is created solely for imaginative purposes.

AstraZeneca TV commercial - Asthma or COPD produced for AstraZeneca was first shown on television on April 27, 2020.

Frequently Asked Questions about astrazeneca tv spot, 'asthma or copd'

BREZTRI AEROSPHERE is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Not indicated for the relief of acute bronchospasm or for the treatment of asthma. Please see full BREZTRI Prescribing Information, including Patient Information.

TRELEGY is the first and only once-daily, 3-in-1 treatment for COPD. With 3 medicines in 1 inhaler, TRELEGY can help you breathe easier and improve lung function. It can also help prevent future flare-ups. TRELEGY does not replace a rescue inhaler.

Tezspire is also in development for other potential indications including chronic obstructive pulmonary disease (COPD), chronic rhinosinusitis with nasal polyps, chronic spontaneous urticaria and eosinophilic esophagitis (EoE).

Tozorakimab is a novel therapeutic agent with a dual mechanism of action that blocks IL-33red and IL-33ox signalling, offering potential to reduce inflammation and epithelial dysfunction in human disease.

Physicians will be able to offer their patients Airsupra, an important new rescue treatment that reduces the risk of asthma exacerbations.” Asthma is a chronic, inflammatory respiratory disease with variable symptoms that affects as many as 262 million people worldwide.

Dr. Rashmi Hegde, Executive Vice President - Medical Affairs, GlaxoSmithKline Pharmaceuticals Limited, said, "We are thrilled to launch Trelegy Ellipta, enabling a greater number of Indian COPD patients to benefit from this world-leading medicine.

Advair is one of the most commonly used inhalers for the maintenance treatment of COPD. It is a combination of fluticasone, a corticosteroid, and salmeterol, a long-acting bronchodilator. Advair is used on a regular basis for the maintenance treatment of COPD and it is typically taken twice per day.

The most common combination inhalers used in COPD have two long-acting bronchodilators (LABA + LAMA): Umeclidinium/vilanterol (Anoro Ellipta) Tiotropium/olodaterol (Stiolto Respimat) Glycopyrrolate/formoterol (Bevespi Aerosphere)

Bronchodilators. Short-acting beta2 agonists (salbutamol or terbutaline) can be used for short-term symptom relief in asthma, COPD and asthma–COPD overlap.

For most people with COPD, short-acting bronchodilator inhalers are the first treatment used. Bronchodilators are medicines that make breathing easier by relaxing and widening your airways. There are 2 types of short-acting bronchodilator inhaler: beta-2 agonist inhalers – such as salbutamol and terbutaline.

Tozorakimab (Synonyms: MEDI-3506) Tozorakimab (MEDI-3506) is a human immunoglobulin G1 monoclonal antibody targeting interleukin-33. Tozorakimab can be used to research chronic obstructive pulmonary disease. For research use only.

Overview. Chronic obstructive pulmonary disease (COPD) is a common lung disease causing restricted airflow and breathing problems. It is sometimes called emphysema or chronic bronchitis. In people with COPD, the lungs can get damaged or clogged with phlegm.

Videos

Watch AstraZeneca TV Commercial, 'Asthma or COPD'

We analyzed TV commercials placed on popular platforms and found the most relevant videos for you:

Agenices

Agenices of the AstraZeneca TV Spot, 'Asthma or COPD'

AstraZeneca TV commercial - Asthma or COPD
Healix

Healix is a healthcare services company based in the United Kingdom that provides innovative and cost-effective medical solutions. The company specializes in administering and managing medical claims...

AstraZeneca TV commercial - Asthma or COPD
Patients & Purpose

Patients & Purpose is a healthcare advertising agency that specializes in creating meaningful connections between brands and patients. The company's mission is to empower patients by helping them acce...

TV commercials

Similar commercials

Chef Boyardee Mini Micro Beef Ravioli TV Commercial Featuring Big Time Rush
Google Nest Audio TV Spot, 'Whole Home Funkifier: Buy Two, Save $30'
Pure Protein TV Spot, 'Derailers: Kid'
Breville TV Spot, 'Juicing vs. Blending Higher Concentrate'
Outback Steakhouse TV Spot, 'Fly In'
Google Nest TV Spot, 'El estéreo portatil bilingüe: ahorra $30'
Google Nest Audio TV Spot, 'Whole Home Funkifier: Kitchen: YouTube Premium'
Google Nest Hub Max TV Spot, 'Dine-In Motivator: $49.99'
Google Nest TV Spot, 'El estéreo portatil bilingüe'
Google Nest Audio TV Spot, 'Whole Home Funkifier: Kitchen'
Westinghouse Wax-Free Fragrance Warmers TV Spot
Revlon Bold Lacquer TV Commercial Featuring Emma Stone